James A. Fyfe

7.0k total citations · 4 hit papers
42 papers, 5.8k citations indexed

About

James A. Fyfe is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, James A. Fyfe has authored 42 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 16 papers in Molecular Biology and 13 papers in Infectious Diseases. Recurrent topics in James A. Fyfe's work include Herpesvirus Infections and Treatments (16 papers), Biochemical and Molecular Research (12 papers) and HIV/AIDS drug development and treatment (12 papers). James A. Fyfe is often cited by papers focused on Herpesvirus Infections and Treatments (16 papers), Biochemical and Molecular Research (12 papers) and HIV/AIDS drug development and treatment (12 papers). James A. Fyfe collaborates with scholars based in United States, United Kingdom and Netherlands. James A. Fyfe's co-authors include Gertrude B. Elion, Phillip A. Furman, Paula Sherman, P A Furman, Paul M. Keller, Lilia M. Beauchamp, Howard J. Schaeffer, P de Miranda, Janet L. Rideout and M H St Clair and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

James A. Fyfe

42 papers receiving 5.4k citations

Hit Papers

Selectivity of action of an antiherpetic agent, 9-(2-hydr... 1977 2026 1993 2009 1977 1986 1978 1979 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
    1977 1.3k citations Gertrude B. Elion, Phillip A. Furman et al. Proceedings of the National Academy of Sciences profile →
  2. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    1986 1.2k citations P A Furman, James A. Fyfe et al. Proceedings of the National Academy of Sciences profile →
  3. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.
    1978 476 citations James A. Fyfe, Paul M. Keller et al. Journal of Biological Chemistry profile →
  4. Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate
    1979 274 citations P A Furman, M H St Clair et al. Journal of Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Fyfe United States 28 3.0k 2.2k 1.9k 1.5k 735 42 5.8k
P A Furman United States 29 2.4k 0.8× 3.1k 1.4× 1.7k 0.9× 2.3k 1.5× 545 0.7× 44 5.7k
M H St Clair United States 28 2.0k 0.7× 3.8k 1.7× 1.8k 0.9× 3.1k 2.1× 493 0.7× 39 6.1k
P de Miranda United States 35 3.5k 1.2× 1.3k 0.6× 1.2k 0.6× 482 0.3× 925 1.3× 68 5.5k
Paul M. Keller United States 44 3.0k 1.0× 774 0.3× 2.0k 1.1× 766 0.5× 598 0.8× 81 6.4k
Earl R. Kern United States 54 6.0k 2.0× 1.5k 0.7× 1.9k 1.0× 1.5k 1.0× 1.2k 1.6× 220 9.2k
Mark N. Prichard United States 39 3.5k 1.2× 1.1k 0.5× 1.4k 0.7× 837 0.6× 797 1.1× 143 5.4k
Sandra Nusinoff Lehrman United States 17 1.5k 0.5× 2.8k 1.3× 1.0k 0.5× 2.2k 1.5× 285 0.4× 21 4.3k
Helga Rübsamen‐Waigmann Germany 35 952 0.3× 1.8k 0.8× 1.8k 0.9× 2.1k 1.4× 576 0.8× 104 5.1k
Phillip A. Furman United States 34 2.7k 0.9× 2.3k 1.0× 1.6k 0.8× 713 0.5× 387 0.5× 73 5.3k
S Broder United States 46 2.0k 0.7× 4.7k 2.1× 2.7k 1.4× 4.1k 2.8× 1.3k 1.8× 96 10.8k

Countries citing papers authored by James A. Fyfe

Since Specialization
Citations

This map shows the geographic impact of James A. Fyfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Fyfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Fyfe more than expected).

Fields of papers citing papers by James A. Fyfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Fyfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Fyfe. The network helps show where James A. Fyfe may publish in the future.

Co-authorship network of co-authors of James A. Fyfe

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Fyfe. A scholar is included among the top collaborators of James A. Fyfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Fyfe. James A. Fyfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elion, Gertrude B., Phillip A. Furman, James A. Fyfe, et al.. (1999). The selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Reviews in Medical Virology. 9(3). 147–153. 34 indexed citations
2.
Weinberg, Jason B., Diane C. Shugars, Paula Sherman, Derrick L. Sauls, & James A. Fyfe. (1998). Cobalamin Inhibition of HIV-1 Integrase and Integration of HIV-1 DNA into Cellular DNA. Biochemical and Biophysical Research Communications. 246(2). 393–397. 20 indexed citations
3.
Fyfe, James A., Shahnaz Rahim, Susan M. Daluge, et al.. (1993). Varicella-Zoster virus thymidine kinase. Biochemical Pharmacology. 46(12). 2209–2218. 12 indexed citations
4.
Sherman, Paula, Matthew Dickson, & James A. Fyfe. (1992). Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions. Journal of Virology. 66(6). 3593–3601. 100 indexed citations
5.
Koszalka, George W., D R Averett, James A. Fyfe, et al.. (1991). 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus. Antimicrobial Agents and Chemotherapy. 35(7). 1437–1443. 11 indexed citations
6.
Prus, Karen, et al.. (1989). 3-Deazaadenosine 5′-triphosphate: A novel metabolite of 3-deazaadenosine in mouse leukocytes. Biochemical Pharmacology. 38(3). 509–517. 12 indexed citations
7.
Sherman, Paula & James A. Fyfe. (1989). Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. Analytical Biochemistry. 180(2). 222–226. 201 indexed citations
8.
Ellis, Mark, Paul M. Keller, James A. Fyfe, et al.. (1987). Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrobial Agents and Chemotherapy. 31(7). 1117–1125. 73 indexed citations
9.
Olsen, John C., P A Furman, James A. Fyfe, & Ronald Swanstrom. (1987). 3'-Azido-3'-deoxythymidine inhibits the replication of avian leukosis virus. Journal of Virology. 61(9). 2800–2806. 10 indexed citations
10.
Furman, P A, James A. Fyfe, M H St Clair, et al.. (1986). Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.. Proceedings of the National Academy of Sciences. 83(21). 8333–8337. 1167 indexed citations breakdown →
11.
Biron, Karen K., James A. Fyfe, Sylvia C. Stanat, et al.. (1986). A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate.. Proceedings of the National Academy of Sciences. 83(22). 8769–8773. 126 indexed citations
12.
Beauchamp, Lilia M., Bart L. Dolmatch, Howard J. Schaeffer, et al.. (1985). Modifications on the heterocyclic base of acyclovir: syntheses and antiviral properties. Journal of Medicinal Chemistry. 28(8). 982–987. 32 indexed citations
13.
14.
Furman, Phillip A., Paul V. McGuirt, Paul M. Keller, James A. Fyfe, & Gertrude B. Elion. (1980). Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with Herpesvirus genetic information. Virology. 102(2). 420–430. 128 indexed citations
15.
Fyfe, James A., Paul M. Keller, P A Furman, Richard L. Miller, & Gertrude B. Elion. (1978). Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.. Journal of Biological Chemistry. 253(24). 8721–8727. 476 indexed citations breakdown →
16.
Miller, Richard L., et al.. (1974). Xanthine phosphoribosyltransferase from Streptococcus faecalis. Archives of Biochemistry and Biophysics. 165(1). 349–358. 9 indexed citations
17.
Fyfe, James A., Donald J. Nelson, & George H. Hitchings. (1974). The Molecular Basis for the Effects of Allopurinol on Pyrimidine Metabolism. Advances in experimental medicine and biology. 41. 621–628. 7 indexed citations
18.
Fyfe, James A., Richard L. Miller, & Thomas A. Krenitsky. (1973). Kinetic Properties and Inhibition of Orotidine 5′-Phosphate Decarboxylase. Journal of Biological Chemistry. 248(11). 3801–3809. 67 indexed citations
19.
Friedmann, Herbert & James A. Fyfe. (1969). Pseudovitamin B12 Biosynthesis. Journal of Biological Chemistry. 244(7). 1667–1671. 12 indexed citations
20.
Anderson, Roger W., et al.. (1965). An Infrared Study of Monosulfatopentaaquochromium(III) Chloride. Inorganic Chemistry. 4(1). 43–45. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P A Furman Breakdown of academic impact, for papers by M H St Clair Breakdown of academic impact, for papers by P de Miranda Breakdown of academic impact, for papers by Paul M. Keller Breakdown of academic impact, for papers by Earl R. Kern Breakdown of academic impact, for papers by Mark N. Prichard Breakdown of academic impact, for papers by Sandra Nusinoff Lehrman Breakdown of academic impact, for papers by Helga Rübsamen‐Waigmann Breakdown of academic impact, for papers by Phillip A. Furman Breakdown of academic impact, for papers by S Broder
Rankless by CCL
2026